Cargando…

PSMA Theranostics: Current Landscape and Future Outlook

SIMPLE SUMMARY: The prognosis for metastatic prostate cancer patients remains poor. Prostate-specific membrane antigen (PSMA) is overexpressed in prostate cancer and is a promising target for both imaging and therapy. In this review paper, we provide an overview of the evidence for PSMA-targeted ima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hanbo, Koumna, Stella, Pouliot, Frédéric, Beauregard, Jean-Mathieu, Kolinsky, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391520/ https://www.ncbi.nlm.nih.gov/pubmed/34439177 http://dx.doi.org/10.3390/cancers13164023

Ejemplares similares

PSMA Theranostics: Current Status and Future Directions
por: Rahbar, Kambiz, et al.
Publicado: (2018)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Kirchner, Maximilian A., et al.
Publicado: (2021)

PSMA-Targeting Imaging and Theranostic Agents—Current Status and Future Perspective
por: Debnath, Sashi, et al.
Publicado: (2022)

Update of PSMA Theranostics in Prostate Cancer: Current Applications and Future Trends
por: Kaewput, Chalermrat, et al.
Publicado: (2022)

PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
por: Jones, Wallace, et al.
Publicado: (2020)

PSMA Theranostics: Science and Practice
por: Mokoala, Kgomotso, et al.
Publicado: (2021)

Advances in PSMA theranostics
por: Jeitner, Thomas M., et al.
Publicado: (2022)

The current status of prostate cancer treatment and PSMA theranostics
por: Uemura, Motohide, et al.
Publicado: (2023)

Potential Targets Other Than PSMA for Prostate Cancer Theranostics: A Systematic Review
por: Gauthé, Mathieu, et al.
Publicado: (2021)

Synthesis of Nanogels: Current Trends and Future Outlook
por: Mauri, Emanuele, et al.
Publicado: (2021)

Antithrombin Therapy: Current State and Future Outlook
por: Rodgers, George M., et al.
Publicado: (2023)

PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
por: Bychkov, Andrey, et al.
Publicado: (2017)

Effect of Carbohydration on the Theranostic Tracer PSMA I&T
por: Schmidt, Alexander, et al.
Publicado: (2018)

PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
por: Flores, Orielyz, et al.
Publicado: (2017)

Helium: Current Status And Future Outlook
por: Fowler, W B
Publicado: (1990)

Current Understandings on Magnesium Deficiency and Future Outlooks for Sustainable Agriculture
por: Chaudhry, Ahmad Hassan, et al.
Publicado: (2021)

Bioengineering tools for the production of pharmaceuticals: current perspective and future outlook
por: Sarsaiya, Surendra, et al.
Publicado: (2019)

MR-Imaging in Osteoarthritis: Current Standard of Practice and Future Outlook
por: Ehmig, Jonathan, et al.
Publicado: (2023)

Clinical translation of microbe‐based therapies: Current clinical landscape and preclinical outlook
por: Vargason, Ava M., et al.
Publicado: (2018)

Prostate-Specific Membrane Antigen (PSMA) Theranostics for Treatment of Oligometastatic Prostate Cancer
por: Plichta, Kristin A., et al.
Publicado: (2021)

PSMA Expression in Solid Tumors beyond the Prostate Gland: Ready for Theranostic Applications?
por: Lauri, Chiara, et al.
Publicado: (2022)

Adaptive designs: current status, future outlook
por: Grieve, Andy
Publicado: (2011)

Current Status and Future Outlook for Nonwovens in Japan
por: Yaida, Osamu
Publicado: (2016)

Conductive Scaffolds for Bone Tissue Engineering: Current State and Future Outlook
por: Dixon, Damion T., et al.
Publicado: (2021)

Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future
por: Prins, Niels D, et al.
Publicado: (2013)

Herbicide Resistance Traits in Maize and Soybean: Current Status and Future Outlook
por: Nandula, Vijay K.
Publicado: (2019)

Current Status and Future Outlook of Additive Manufacturing Technologies for the Reconstruction of the Trachea
por: Lee, Hwa-Yong, et al.
Publicado: (2023)

mRNA vaccine in cancer therapy: Current advance and future outlook
por: Li, Youhuai, et al.
Publicado: (2023)

The Future Outlook
Publicado: (1919)

The Outlook for the Future
Publicado: (1903)

Spotlight on PSMA as a new theranostic biomarker for bladder cancer
por: Tumedei, Maria Maddalena, et al.
Publicado: (2021)

A Review of 177Lutetium-PSMA and 225Actinium-PSMA as Emerging Theranostic Agents in Prostate Cancer
por: Alam, Mohammad R, et al.
Publicado: (2022)

Theranostics of Primary Prostate Cancer: Beyond PSMA and GRP-R
por: Schollhammer, Romain, et al.
Publicado: (2023)

Swarming Behavior in Anopheles gambiae (sensu lato): Current Knowledge and Future Outlook
por: Baeshen, Rowida
Publicado: (2021)

Image-Guided Transurethral Resection of Bladder Tumors – Current Practice and Future Outlooks
por: Chang, Timothy C., et al.
Publicado: (2017)

Combined biology-guided radiotherapy and Lutetium PSMA theranostics treatment in metastatic castrate-resistant prostate cancer
por: Gaudreault, Mathieu, et al.
Publicado: (2023)

BioDynaMo: Current Status and Future Outlook
por: Breitwieser, Lukas
Publicado: (2021)

Low-dose antibiotics: current status and outlook for the future
por: Nosanchuk, Joshua D., et al.
Publicado: (2014)

Diffuse correlation spectroscopy: current status and future outlook
por: Carp, Stefan A., et al.
Publicado: (2023)

An Outlook on Global Regulatory Landscape for Genome-Edited Crops
por: Ahmad, Aftab, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3s42mm8q9oiie7864ao887cqnq